Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Caleb Skipper"'
Publikováno v:
IDCases, Vol 19, Iss , Pp - (2020)
We describe a case of central venous catheter infection and bacteremia caused by Bosea thiooxidans, which has not been previously described in the literature. Bosea spp. is a gram-negative bacterium that has been isolated from hospital water supplies
Externí odkaz:
https://doaj.org/article/cb9a8c88ebdb4c8ab440b19087997b3f
Autor:
Rachel R. Atherton, Fiona V. Cresswell, Jayne Ellis, Caleb Skipper, Kiiza K. Tadeo, Gerald Mugumya, Vincent Wadda, David B. Meya, David R. Boulware
Publikováno v:
International Journal of Infectious Diseases, Vol 75, Iss , Pp 92-94 (2018)
In January 2017, the World Health Organisation recommended the Xpert® MTB/RIF Ultra assay (Ultra) for tuberculosis (TB) diagnosis. Ultra offers improved analytical sensitivity when compared with the initial Xpert® MTB/RIF (Xpert) assay for the dete
Externí odkaz:
https://doaj.org/article/e5df2f75d48f4d34af3ddbd3702c1431
Publikováno v:
Journal of Fungi, Vol 5, Iss 3, p 65 (2019)
Cryptococcal meningitis persists as a significant source of morbidity and mortality in persons with HIV/AIDS, particularly in sub-Saharan Africa. Despite increasing access to antiretrovirals, persons presenting with advanced HIV disease remains commo
Externí odkaz:
https://doaj.org/article/712a510c0c58406db27b9005e93bcb5f
Autor:
Mucunguzi Atukunda, Enock Kagimu, Morris K Rutakingirwa, Lillian Tugume, Laura Nsangi, Abdu Musubire, Jane Gakuru, Timothy Mugabi, Andrew Akampurira, Kenneth Ssebambulidde, John Kasibante, Jayne Ellis, Edward Mpoza, Darlisha A Williams, Ann M Fieberg, Caleb Skipper, Mahsa Abassi, Kathy Huppler Hullsiek, David Meya, David R Boulware
Publikováno v:
Open Forum Infectious Diseases. 9
Background Intravenous (IV) amphotericin B is the gold standard treatment of severe mycoses. A new orally absorbed, less-toxic formulation of amphotericin has been developed (Matinas Biopharma). We evaluated the efficacy of this novel anti-fungal age
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c57d7d59d02240e8135d9b655743fa2e
https://doi.org/10.1093/ofid/ofac492.062
https://doi.org/10.1093/ofid/ofac492.062
Publikováno v:
Cureus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5c1b6fabb1976ed0f5ed07f7bbecded
https://doi.org/10.7759/cureus.22848
https://doi.org/10.7759/cureus.22848
Autor:
Supavit Chesdachai, Radha Rajasingham, Melanie R Nicol, David Meya, Felix Bongomin, Mahsa Abassi, Caleb Skipper, Richard Kwizera, Joshua Rhein, David Boulware
Publikováno v:
Open Forum Infectious Diseases
Background Fluconazole is lifesaving for the treatment and prevention of cryptococcosis; however, optimal dosing is unknown. Initial fluconazole doses of 100 mg to 2000 mg/day have been used. Prevalence of fluconazole non-susceptible Cryptococcus is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57b7f86486a555e8db3f2ea81e980947
http://europepmc.org/articles/PMC6809647
http://europepmc.org/articles/PMC6809647
Autor:
Supavit Chesdachai, Nicole Engen, Joshua Rhein, Lillian Tugume, Tadeo kiiza. Kandole, Mahsa Abassi, Darlisha A Williams, Caleb Skipper, Kathy H Hullsiek, Abdu kisekka. Musubire, David Meya, David Boulware
Publikováno v:
Open Forum Infectious Diseases
Background C-reactive protein (CRP) is an acute-phase protein produced by the liver in response to systemic inflammation. CRP is a helpful surrogate biomarker widely used in various infections, particularly for following the progression and resolutio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8b71b32d8ab710c56ec7c96df133725
https://doi.org/10.1093/ofid/ofz360.1579
https://doi.org/10.1093/ofid/ofz360.1579